Spectants is pioneering a breakthrough point-of-care platform for rapid, ultra-sensitive cardiac biomarker detection Our technology measures cardiac troponin (cTn) levels to assess heart muscle damage with lab-grade accuracy in minutes Our mission is to empower clinicians with precise diagnostic tools that: 1) Identify high-risk patients accurately 2) Efficiently rule out low-risk individuals 3) Reduce healthcare costs through enhanced diagnostic precision and optimized resource allocation
| Website | https://spectants.com/ |
| Employees | 7 (4 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular Spectants employee's phone or email?
Gloria Volohonsky is the CTO of Spectants.
4 people are employed at Spectants.
Spectants is based in Strasbourg, Grand Est.